Rise in antipsychotics prescriptions during pandemic warrant closer look, feds say
Apr 11, 2022
A federal study has found that prescriptions for antipsychotic medication in nursing homes and assisted living facilities increased by 7.4% during the first quarter, or first three months, of the pandemic.
As antipsychotic use appears to backslide among nursing home residents, risks mount
Oct 11, 2021
For more than a decade, patient advocates and federal regulators have called for a reduction in nursing homes’ use of antipsychotic medications, a class of drugs once widely associated with controlling...
Antipsychotic misuse citations down 22%; drugs given 10 times too often: House report
Jul 29, 2020
Skilled nursing providers have received far fewer citations for antipsychotic misuse under the Trump administration, according to authors of a report released Monday by Democrats on the House Ways and...
Researchers: Campaign against antipsychotics may have led to rise in riskier drug use
Mar 20, 2018
Instead of decreasing drug use, prescribers looking to treat behavioral issues among dementia patients merely may be shifting from antipsychotics to mood stabilizers.
Withering report on misuse of antipsychotics in nursing homes overlooks industry efforts to improve,...
Feb 06, 2018
Those who care for the nation’s seniors have been leaders in reducing the inappropriate use of antipsychotic medications in skilled nursing settings, advocates said Monday in response to a scathing...
Also in the News for Monday, Jan. 29
Jan 29, 2018
The anti- antipsychotics message might not be getting through to LTC nurses … New research solidifies connection between high-sugar diet and cognitive decline … Aid-in-dying movement pushes...
Long-stay antipsychotic use reductions may require more scrutiny, study suggests
Dec 07, 2017
Reductions in antipsychotic use in long-stay nursing home residents may reflect more residents being diagnosed with mental health conditions excluded from quality measurement audits, a new study suggests.
Goal: 15% drop in psych drugs
James M. Berklan
Nov 06, 2017
The Centers for Medicare & Medicaid Services is hoping that providers can add to their success when it comes to further lowering the use of antipsychotic medications in nursing homes.
The unspoken cost of restraint
Oct 18, 2017
Thankfully, the practice of using physical restraints for older adults living with dementia has largely been relegated to the past.
CMS: Nursing homes with high antipsychotic rates should aim for a 15% reduction by end of 2019
Oct 05, 2017
The Centers for Medicare & Medicaid Services has met its latest goal for antipsychotic reduction in nursing homes, and with it set a new one for under-performing providers: cutting antipsychotic use by...